In vivo magnetic resonance spectroscopy detection of combined glutamate-glutamine in healthy upper cervical cord at 3T

NMR in Biomedicine

Volumn 26, Issue 3, 2013, Pages 357-366

  Solanky, Bhavana S ^a   Abdel Aziz, Khaled ^a   Yiannakas, Marios C ^a   Berry, Alaine M ^a   Ciccarelli, Olga ^a   Wheeler Kingshott, Claudia A M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

1H; Glutamate; Glutamine; MRS; PRESS; Spinal cord; STEAM

Indexed keywords

1H; GLUTAMATE; GLUTAMINE; MRS; SPINAL CORDS;

AMINO ACIDS; MAGNETIC RESONANCE SPECTROSCOPY; SAMPLING; STEAM;

PRESSES (MACHINE TOOLS);

GLUTAMIC ACID; GLUTAMINE;

ADULT; ARTICLE; CERVICAL SPINAL CORD; COMPARATIVE STUDY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SIMULATION;

ADULT; ALGORITHMS; CERVICAL VERTEBRAE; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROTRANSMITTER AGENTS; REFERENCE VALUES; SPINAL CORD;

EID: 84873985719     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2867     Document Type: Article

References (38)

1. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 2004; 61(6): 657-668.
2. Cavalla P, Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropath. Exp. Neur. 2007; 66(8): 732-739.
3. Valiakalayil A, Hanstock C, Seres P, Purdon S, Tibbo R. Proton MRS investigation of glutamate levels and executive functioning in first episode psychosis. Schizophr. Res. 2006; 86: S69-S69.
4. Doble A. The role of excitotoxicity in neurodegenerative disease: Implications for therapy. Pharmacol. Therapeut. 1999; 81(3): 163-221.
5. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 1992; 326(22): 1464-1468.
6. Hugon J, Vallat JM, Dumas M. Role of glutamate and excitotoxicity in neurologic diseases. Rev. Neurol. (Paris) 1996; 152(4): 239-248.
7. Maudsley AA, Govindaraju V, Young K. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13(3): 129-153.
8. Hancu I. Optimized Glutamate Detection at 3T. J. Magn. Reson. Imaging 2009; 30: 8.
9. Shimohama S, Urushitani M, Kihara T, Sawada H, Akaike A, Ibi M, Inoue R, Kitamura Y, Taniguchi T, Kimura J. Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: Involvement of glutamate induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann. Neurol. 1998; 44(5): 796-807.
10. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magnet. Reson. Med. 2004; 51(3): 435-440.
11. Mayer D, Spielman DM. Detection of glutamate in the human brain at 3T using optimized constant time point resolved spectroscopy. Magnet. Reson. Med. 2005; 54(2): 439-442.
12. Bot JCJ, Barkhof F, Nijeholt GLA, van Schaardenburg D, Voskuyl AE, Ader HJ, Pijnenburg JAL, Polman CH, Uitdehaag BMJ, Vermeulen EGJ, Castelijns JA. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: Valus of spinal MR imaging. Radiology 2002; 223(1): 46-56.
13. Honig LS, Sheremata WA. Magnetic-resonance imaging of spinal-cord lesions in multiple-sclerosis. J. Neurol. Neurosur. Ps. 1989; 52(4): 459-466.
14. Kim YG, Choi GH, Kim DH, Kim YD, Kang YK, Kim JK. In vivo proton magnetic resonance spectroscopy of human spinal mass lesions. J. Spinal Disord. Tech. 2004; 17(5): 405-411.
15. Soher BJ, Semanchuk P, Todd D, Steinberg J, Young K. VeSPA: Integrated applications for RF pulse design, spectral simulation and MRS data analysis. 2011; Montreal. p 1410.
16. Soher BJ, Young K, Bernstein A, Aygula Z, Maudsley AA. GAVA: Spectral simulation for in vivo MRS applications. J. Magn. Reson. 2007; 185(2): 291-299.
17. Yiannakas MC, Kearney H, Samson RS, Chard DT, Ciccarelli O, Wheeler-Kingshott CAM. Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: A pilot study with application to magnetisation transfer measurements. Neuroimage 2012; 63(3): 1054-1059.
18. Henning A, Schar M, Kollias SS, Boesiger P, Dydak U. Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magnet. Reson. Med. 2008; 59(6): 1250-1258.
19. Cooke FJ, Blamire AM, Manners DN, Styles P, Rajagopalan B. Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magnet. Reson. Med. 2004; 51(6): 1122-1128.
20. Morris GA, Freeman R. Selective excitation in Fourier-transform nuclear magnetic-resonance. J. Magn. Reson. 1978; 29(3): 433-462.
21. Patt SL, Sykes BD. Water eliminated Fourier-transform NMR-spectroscopy. J. Chem. Phys. 1972; 56(6): 3182.
22. Haase A, Frahm J, Hanicke W, Matthaei D. H-1-Nmr chemical-shift selective (Chess) imaging. Phys. Med. Biol. 1985; 30(4): 341-344.
23. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo H-1 NMR spectroscopy of rat brain at 1ms echo time. Magnet. Reson. Med. 1999; 41(4): 649-656.
24. Smith SA, Levante TO, Meier BH, Ernst RR. Computer simulations in magnetic resonance - an object-oriented programming approach. J. Magn. Reson. Ser. A. 1994; 106(1): 75-105.
25. Provencher SW. Automatic quantitation of localized in vivo H-1 spectra with LCModel. NMR Biomed. 2001; 14(4): 260-264.
26. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat. Med. 2000; 19(9): 1141-1164.
27. Edden RA, Bonekamp D, Smith MA, Dubey P, Barker PB. Proton MR spectroscopic imaging of the medulla and cervical spinal cord. J. Magn. Reson. Imaging 2007; 26(4): 1101-1105.
28. Marliani AF, Clementi V, Albini-Riccioli L, Agati R, Leonardi M. Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magnet. Reson. Med. 2007; 57(1): 160-163.
29. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, Cercignani M, Wimpey K, Miller DH, Thompson AJ. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130: 2220-2231.
30. Smith SA, Edden RA, Farrell JA, Barker PB, Van Zijl PC. Measurement of T1 and T2 in the cervical spinal cord at 3 tesla. Magn. Reson. Med. 2008; 60(1): 213-219.
31. Gomez-Anson B, MacManus DG, Parker GJM, Davie CA, Barker GJ, Moseley IF, McDonald WI, Miller DH. In vivo (1)H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 2000; 42(7): 515-517.
32. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, Cercignani M, Wimpey K, Miller DH, Thompson AJ. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130(Pt 8): 2220-2231.
33. Carew JD, Nair G, Pineda-Alonso N, Usher S, Hu X, Benatar M. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011; 12(3): 185-191.
34. Kaiser LG, Schuff N, Cashdollar N, Weiner MW. Age-related glutamate and glutamine concentration changes in normal human brain: H-1 MR spectroscopy study at 4T. Neurobiol. Aging 2005; 26(5): 665-672.
35. Chang L, Jiang CS, Ernst T. Effects of age and sex on brain glutamate and other metabolites. Magn. Reson. Imaging 2009; 27(1): 142-145.
36. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005; 128: 1016-1025.
37. O'Gorman RL, Michels L, Edden RA, Murdoch JB, Martin E. In vivo detection of GABA and glutamate with MEGA-PRESS: reproducibility and gender effects. J. Magn. Reson. Imaging 2011; 33(5): 1262-1267.
38. Wijtenburg SA, Knight-Scott J. Very short echo time improves the precision of glutamate Detection at 3T in (1)H magnetic resonance spectroscopy. J. Magn. Reson. Imaging 2011; 34(3): 645-652.